Tanespimycin (17-AAG)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tanespimycin (17-AAG), covering 2013-06-04 to 2013-06-26. Get the full timeline:
Most recent: Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma [Phase 2]